UA Frame EN

Welcome to licensed pharmacies in Poland:

Non-prescription medicines delivery across Europe.

Frequently ordered: potency boosters (sildenafil OTC), quit smoking aids.

Manuela  (Anonymous, 178.115.51.) Warszawa 6 months ago

I have depression-predominantly bipolar disorder and have been prescribed Reagila 1.5mg – does anyone have experience with this drug?

I have bipolar disorder but mostly depression. I was prescribed Reagila 1.5 mg today. Who has experience with this, with the same diagnosis? Thank you

1 answer

* required field

You can drag the photo file here.

* required field

Notify of a new answer.
Other messages will not be sent.

Suggested Products

Space for your product

Your product would fit here?

Set up a sponsored products campaign yourself:

Check

Anna Lewandowska Pharmacist, Editor

6 months ago

Reagila (cariprazine) is a medication used to treat manic and depressive episodes in bipolar disorder. It can be effective in stabilizing mood and relieving symptoms of depression. The effect of the drug develops gradually, so the effects may not be visible until several weeks. It is important to monitor for side effects, such as insomnia or nausea, and to see your doctor regularly to assess the effectiveness and tolerability of your treatment. If doubts arise or symptoms intensify, it is worth consulting a psychiatrist.

If you need more personalized advice, you can use teleconsultations here:

https://www.gdziepolek.pl/telekonsultacja

The advice is provided in Polish.

The availability of Reagila in pharmacies in Polish can be checked at the following address:

https://www.gdziepolek.pl/produkty/98044/reagila-kapsulki/apteki

Appreciate the answerer and highlight the question on the home page
User questions and answers that provide feedback about products are not verified for the purchase or use of the product. Companies often order anonymous comments to form positive opinions about their products, or negative ones about competitors. Therefore, be guided by the information in the pharmacists' responses in the first place.

Specialists